Du-Young Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Du-Young Choi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Cheol Hwan So
Department of Pediatrics, Wonkwang University School of Medicine, Iksan, Korea
1 shared publication- Cheol Lee
Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine, Iksan-si, Jeonbuk-do, Republic of Korea
1 shared publication Do-Jin Lee
Department of Pediatrics, Wonkwang University School of Medicine Hospital, Iksan, Korea
1 shared publication- Eunsung Park
Department of Neurosurgery, Wonkwang University School of Medicine Hospital, 895 Muwang-ro, Iksan-si 54538, Jeonbuk, Republic of Korea
1 shared publication - Hien Thi Tuong
Zoonosis Research Center, Department of Infection Biology, School of Medicine, Wonkwang University, Iksan 570-749, Korea
1 shared publication - Hongbo Li
College of Civil and Hydraulic Engineering, Ningxia University, Yinchuan 750021, China
1 shared publication
Latest Publications
- Open Access
- 21 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5908
Comparison of Pulsed Radiofrequency and Endoscopic Piriformis Release for Refractory Piriformis Syndrome: A Propensity Score-Matched Retrospective Cohort Study
Background/Objective: Piriformis syndrome (PS) causes sciatic nerve entrapment and chronic pain. In refractory cases, pulsed radiofrequency (PRF) and endoscopic piriformis release (EPR) are used, but comparative evidence is limited. Methods: This retrospective cohort study compared PRF and EPR in patients treated from 2018 to 2024 at a tertiary hospital using propensity score matching (PSM). Patients with PS, unresponsive to conservative treatment (≥3 months), were included. PRF targeted the sciatic nerve under imaging guidance; EPR involved endoscopic decompression. Primary outcomes were Numeric Rating Scale (NRS) scores at 3 and 6 months. Secondary outcomes included patient satisfaction, reintervention rates, complications, and the Oswestry Disability Index (ODI), where available. After PSM, 115 patients were analyzed per cohort. Multivariate regression identified the predictors of pain improvement. Results: From 465 eligible patients (PRF 350; EPR 115), after PSM, 230 patients were analyzed (115 per cohort). The baseline NRS score was 7.4 ± 1.4 (PRF) vs. 7.5 ± 1.3 (EPR). At 3 months, EPR showed a lower NRS score (2.6 ± 1.3) compared to PRF (3.2 ± 1.6; p = 0.032). At 6 months, the EPR NRS score was 2.2 ± 1.1 vs. 2.9 ± 1.5 for PRF (p = 0.018). EPR had a higher rate of ≥50% NRS score reduction (78% vs. 65%; p = 0.041). EPR patients reported higher satisfaction and fewer reinterventions but more complications. Regression analysis identified EPR (OR = 2.15), higher baseline NRS scores, and shorter symptom duration as predictors of improvement. Conclusions: EPR provided superior pain relief compared to PRF at 3 and 6 months, although with a higher risk of complications. PRF remains a safer initial option.
- 21 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5908
Open AccessComparison of Pulsed Radiofrequency and Endoscopic Piriformis Release for Refractory Piriformis Syndrome: A Propensity Score-Matched Retrospective Cohort Study
Background/Objective: Piriformis syndrome (PS) causes sciatic nerve entrapment and chronic pain. In refractory cases, pulsed radiofrequency (PRF) and endoscopic piriformis release (EPR) are used, but comparative evidence is limited. Methods: This retrospective cohort study compared PRF and EPR in patients treated from 2018 to 2024 at a tertiary hospital using propensity score matching (PSM). Patients with PS, unresponsive to conservative treatment (≥3 months), were included. PRF targeted the sciatic nerve under imaging guidance; EPR involved endoscopic decompression. Primary outcomes were Numeric Rating Scale (NRS) scores at 3 and 6 months. Secondary outcomes included patient satisfaction, reintervention rates, complications, and the Oswestry Disability Index (ODI), where available. After PSM, 115 patients were analyzed per cohort. Multivariate regression identified the predictors of pain improvement. Results: From 465 eligible patients (PRF 350; EPR 115), after PSM, 230 patients were analyzed (115 per cohort). The baseline NRS score was 7.4 ± 1.4 (PRF) vs. 7.5 ± 1.3 (EPR). At 3 months, EPR showed a lower NRS score (2.6 ± 1.3) compared to PRF (3.2 ± 1.6; p = 0.032). At 6 months, the EPR NRS score was 2.2 ± 1.1 vs. 2.9 ± 1.5 for PRF (p = 0.018). EPR had a higher rate of ≥50% NRS score reduction (78% vs. 65%; p = 0.041). EPR patients reported higher satisfaction and fewer reinterventions but more complications. Regression analysis identified EPR (OR = 2.15), higher baseline NRS scores, and shorter symptom duration as predictors of improvement. Conclusions: EPR provided superior pain relief compared to PRF at 3 and 6 months, although with a higher risk of complications. PRF remains a safer initial option.
- Open Access
- 6 May 2024
- Published by Elsevier in Nano Energy
- Vol. 127, 109695
Micro-layered film and foam alternating structures: A novel passive daytime radiative cooling material
- 6 May 2024
- Published by Elsevier in Nano Energy
- Vol. 127, 109695
Open AccessMicro-layered film and foam alternating structures: A novel passive daytime radiative cooling material
- 30 April 2023
- Published by The Korean Society of Pediatric Hematology-Oncology in Clinical Pediatric Hematology-Oncology
- Vol. 30 (1) , 30-35
Thrombotic Thrombocytopenic Purpura as the First Symptom of Systemic Lupus Erythematosus: A Case Report with Review of Literature
Young Min Jo, Cheol Hwan So and Du Young Choi. CPHO 2023;30:30-5. https://doi.org/10.15264/cpho.2023.30.1.30
- 30 April 2023
- Published by The Korean Society of Pediatric Hematology-Oncology in Clinical Pediatric Hematology-Oncology
- Vol. 30 (1) , 30-35
Thrombotic Thrombocytopenic Purpura as the First Symptom of Systemic Lupus Erythematosus: A Case Report with Review of Literature
Young Min Jo, Cheol Hwan So and Du Young Choi. CPHO 2023;30:30-5. https://doi.org/10.15264/cpho.2023.30.1.30
- Open Access
- 31 July 2022
- Published by The Institute of Medical Science, Chosun University in Medical Biological Science and Engineering
- Vol. 5 (2) , 87-90
A lupus anticoagulant-hypoprothrombinemia syndrome patient with adenovirus infection who was accidentally diagnosed after trauma
- 31 July 2022
- Published by The Institute of Medical Science, Chosun University in Medical Biological Science and Engineering
- Vol. 5 (2) , 87-90
Open AccessA lupus anticoagulant-hypoprothrombinemia syndrome patient with adenovirus infection who was accidentally diagnosed after trauma
- Open Access
- 2 October 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (10) , 3013
Development of a Rapid Fluorescent Immunochromatographic Test to Detect Respiratory Syncytial Virus
Human respiratory syncytial virus (RSV) is one of the most common viruses infecting the respiratory tracts of infants. The rapid and sensitive detection of RSV is important to minimize the incidence of infection. In this study, novel monoclonal antibodies (mAbs; B11A5 and E8A11) against RSV nucleoprotein (NP) were developed and applied to develop a rapid fluorescent immunochromatographic strip test (FICT), employing europium nanoparticles as the fluorescent material. For the FICT, the limits of detection of the antigen and virus were 1.25 µg/mL and 4.23 × 106 TCID50/mL, respectively, corresponding to 4.75 × 106 ± 5.8 ×105 (mean ± SD) RNA copy numbers per reaction mixture for RSV NP. A clinical study revealed a sensitivity of 90% (18/20) and specificity of 98.18% (108/110) for RSV detection when comparing the performance to that of reverse transcription polymerase chain reaction (RT-PCR), representing a 15% improvement in sensitivity over the SD Bioline rapid kit. This newly developed FICT could be a useful tool for the rapid diagnosis of RSV infection.
- 2 October 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (10) , 3013
Open AccessDevelopment of a Rapid Fluorescent Immunochromatographic Test to Detect Respiratory Syncytial Virus
Human respiratory syncytial virus (RSV) is one of the most common viruses infecting the respiratory tracts of infants. The rapid and sensitive detection of RSV is important to minimize the incidence of infection. In this study, novel monoclonal antibodies (mAbs; B11A5 and E8A11) against RSV nucleoprotein (NP) were developed and applied to develop a rapid fluorescent immunochromatographic strip test (FICT), employing europium nanoparticles as the fluorescent material. For the FICT, the limits of detection of the antigen and virus were 1.25 µg/mL and 4.23 × 106 TCID50/mL, respectively, corresponding to 4.75 × 106 ± 5.8 ×105 (mean ± SD) RNA copy numbers per reaction mixture for RSV NP. A clinical study revealed a sensitivity of 90% (18/20) and specificity of 98.18% (108/110) for RSV detection when comparing the performance to that of reverse transcription polymerase chain reaction (RT-PCR), representing a 15% improvement in sensitivity over the SD Bioline rapid kit. This newly developed FICT could be a useful tool for the rapid diagnosis of RSV infection.